{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:08:16Z","timestamp":1791209296925,"version":"4.1.0"},"reference-count":25,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100002799","name":"Capital Medical University","doi-asserted-by":"publisher","award":["12300124"],"award-info":[{"award-number":["12300124"]}],"id":[{"id":"10.13039\/501100002799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L242063"],"award-info":[{"award-number":["L242063"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L252054"],"award-info":[{"award-number":["L252054"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372018"],"award-info":[{"award-number":["82372018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We report the first-in-human evaluation of [18F]BIBD-181, a novel SV2A tracer designed with a fluoropropyl side chain to enable mild, automated radiosynthesis. A fully automated cGMP-compliant production process was developed on a commercial synthesizer, yielding the tracer with &amp;gt;95% radiochemical purity and molar activity &amp;gt;130 GBq\/\u03bcmol. In eight healthy volunteers, [18F]BIBD-181 demonstrated excellent safety, rapid brain penetration peaking at 15 s post-injection, and a regional uptake pattern consistent with known synaptic vesicle glycoprotein 2A (SV2A) distribution (pallidum SUV = 2.01 \u00b1 0.57 at 30 min). The effective dose was 2.7 \u03bcSv\/MBq, with predominant renal clearance and no detectable defluorination. In pilot epilepsy patients, [18F]BIBD-181 positron emission tomography (PET) results revealed focal SV2A reductions that were confined to the epileptogenic lesions\ue5f8a sclerotic hippocampus in one patient and a focal cortical dysplasia (FCD) in another\ue5f8whereas [18F]FDG showed either extensive ipsilateral temporal hypometabolism or concordant focal hypometabolism, suggesting that SV2A imaging may offer more precise lesion delineation, particularly when [18F]FDG abnormalities extend beyond the true epileptogenic zone. These findings establish [18F]BIBD-181 as a clinically practical SV2A PET tracer with favorable dosimetry, simplified production, and promising utility for epilepsy surgical planning, warranting further validation in larger cohorts.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.6c01052","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:01:45Z","timestamp":1790179305000},"page":"5151-5160","source":"Crossref","is-referenced-by-count":0,"title":["First-In-Human PET Imaging of Synaptic Vesicle Glycoprotein 2A with [18F]BIBD-181: Automation, Biodistribution, Dosimetry, and Preliminary Application in Epilepsy"],"prefix":"10.1021","volume":"23","author":[{"given":"Zhen","family":"Qiao","sequence":"first","affiliation":[{"name":"Capital Medical University , , ,","place":["Beijing, China, 100071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Li","sequence":"additional","affiliation":[{"name":"Capital Medical University , , ,","place":["Beijing, China, 100071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Capital Medical University , , ,","place":["Beijing, China, 100071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2390-1912","authenticated-orcid":true,"given":"Xiaobin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Capital Medical University , , ,","place":["Beijing, China, 100071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Yang","sequence":"additional","affiliation":[{"name":"Capital Medical University , , ,","place":["Beijing, China, 100071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Sun","sequence":"additional","affiliation":[{"name":"Capital Medical University , , ,","place":["Beijing, China, 100069"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualong","family":"Chen","sequence":"additional","affiliation":[{"name":"Capital Medical University , , ,","place":["Beijing, China, 100069"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebo","family":"Cheng","sequence":"additional","affiliation":[{"name":"Capital Medical University , , ,","place":["Beijing, China, 100069"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Liu","sequence":"additional","affiliation":[{"name":"Capital Medical University , , ,","place":["Beijing, China, 100069"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ai","sequence":"additional","affiliation":[{"name":"Capital Medical University , , ,","place":["Beijing, China, 100071"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-3827","authenticated-orcid":true,"given":"Zehui","family":"Wu","sequence":"additional","affiliation":[{"name":"Capital Medical University , , ,","place":["Beijing, China, 100069"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"2026100509324694400_cit1","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1111\/ejn.12360","article-title":"Synaptic vesicle protein 2A: Basic facts and role in synaptic function","volume":"38","author":"Mendoza-Torreblanca","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"2026100509324694400_cit2","doi-asserted-by":"publisher","first-page":"864514","DOI":"10.3389\/fnins.2022.864514","article-title":"Synaptic vesicle glycoprotein 2A: Features and functions","volume":"16","author":"Rossi","year":"2022","journal-title":"Front. Neurosci."},{"key":"2026100509324694400_cit3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/jnc.13713","article-title":"Synaptopathies: Synaptic dysfunction in neurological disorders \u2212 A review from students to students","volume":"138","author":"Lepeta","year":"2016","journal-title":"J. Neurochem."},{"key":"2026100509324694400_cit4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mcn.2019.02.001","article-title":"Synaptic vesicle protein 2A as a potential biomarker in synaptopathies","volume":"97","author":"Heurling","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"2026100509324694400_cit5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neulet.2018.07.038","article-title":"PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases","volume":"691","author":"Cai","year":"2019","journal-title":"Neurosci. Lett."},{"key":"2026100509324694400_cit6","doi-asserted-by":"publisher","first-page":"1380561","DOI":"10.3389\/fnagi.2024.1380561","article-title":"SV2A PET imaging in human neurodegenerative diseases","volume":"16","author":"Bavarsad","year":"2024","journal-title":"Front. Neurosci."},{"key":"2026100509324694400_cit7","doi-asserted-by":"publisher","first-page":"348ra96","DOI":"10.1126\/scitranslmed.aaf6667","article-title":"Imaging synaptic density in the living human brain","volume":"8","author":"Finnema","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"2026100509324694400_cit8","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2967\/jnumed.115.168179","article-title":"Synthesis and preclinical evaluation of 11C-UCB-J as a PET tracer for imaging the synaptic vesicle glycoprotein 2A in the brain","volume":"57","author":"Nabulsi","year":"2016","journal-title":"J. Nucl. Med."},{"key":"2026100509324694400_cit9","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1177\/0271678x17724947","article-title":"Kinetic evaluation and test-retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans","volume":"38","author":"Finnema","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"2026100509324694400_cit10","doi-asserted-by":"publisher","first-page":"8955","DOI":"10.1021\/acs.jmedchem.6b00905","article-title":"Enabling efficient positron emission tomography (PET) imaging of synaptic vesicle glycoprotein 2A (SV2A) with a robust and one-step radiosynthesis of a highly potent 18F-labeled ligand ([18F]UCB-H)","volume":"59","author":"Warnier","year":"2016","journal-title":"J. Med. Chem."},{"key":"2026100509324694400_cit11","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/acs.molpharmaceut.7b00235","article-title":"Pharmacokinetic characterization of [18F]UCB-H PET radiopharmaceutical in the rat brain","volume":"14","author":"Becker","year":"2017","journal-title":"Mol. Pharmaceutics"},{"key":"2026100509324694400_cit12","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1021\/acschemneuro.8b00526","article-title":"Synthesis and in vivo evaluation of a novel PET radiotracer for imaging of synaptic vesicle glycoprotein 2A (SV2A) in nonhuman primates","volume":"10","author":"Li","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"2026100509324694400_cit13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1021\/acschemneuro.9b00618","article-title":"Synthesis and preclinical evaluation of an 18F-labeled synaptic vesicle glycoprotein 2A PET imaging probe: [18F]SynVesT-2","volume":"11","author":"Cai","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"2026100509324694400_cit14","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1021\/acsmedchemlett.2c00062","article-title":"[18F]BIBD-181: A novel positron emission tomography tracer specific for synaptic vesicle glycoprotein 2A","volume":"13","author":"Jiang","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"2026100509324694400_cit15","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1021\/acs.molpharmaceut.5c01088","article-title":"[18F]BIBD-239: A first-in-human PET radiotracer with dual diagnostic utility for glioma grading and myocardial imaging","volume":"22","author":"Wang","year":"2025","journal-title":"Mol. Pharmaceutics"},{"key":"2026100509324694400_cit16","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.2967\/jnumed.113.136143","article-title":"Evaluation of 18F-UCB-H as a novel PET tracer for synaptic vesicle protein 2A in the brain","volume":"55","author":"Warnock","year":"2014","journal-title":"J. Nucl. Med."},{"key":"2026100509324694400_cit17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s11307-014-0820-6","article-title":"Biodistribution and radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H: First-in-human study","volume":"17","author":"Bretin","year":"2015","journal-title":"Mol. Imaging Biol."},{"key":"2026100509324694400_cit18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.trci.2017.08.004","article-title":"Measuring brain synaptic vesicle protein 2A with positron emission tomography and [18F]UCB-H","volume":"3","author":"Bahri","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"2026100509324694400_cit19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.nucmedbio.2016.03.004","article-title":"[11C]UCB-A, a novel PET tracer for synaptic vesicle protein 2A","volume":"43","author":"Estrada","year":"2016","journal-title":"Nucl. Med. Biol."},{"key":"2026100509324694400_cit20","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/s0140-6736(11)60890-8","article-title":"The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: A cohort study","volume":"378","author":"de Tisi","year":"2011","journal-title":"Lancet"},{"key":"2026100509324694400_cit21","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s00259-024-06656-3","article-title":"EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy","volume":"51","author":"Traub-Weidinger","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2026100509324694400_cit22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/wco.0000000000000527","article-title":"PET and ictal SPECT can be helpful for localizing epileptic foci","volume":"31","author":"von Oertzen","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"2026100509324694400_cit23","doi-asserted-by":"publisher","first-page":"974","DOI":"10.2967\/jnumed.125.271505","article-title":"Detection of focal lesions in epilepsy with [18F]UCB-H synaptic vesicle protein 2A PET imaging","volume":"67","author":"Pakula","year":"2026","journal-title":"J. Nucl. Med."},{"key":"2026100509324694400_cit24","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00259-024-06593-1","article-title":"[18F]SynVesT-1 and [18F]FDG quantitative PET imaging in the presurgical evaluation of MRI-negative children with focal cortical dysplasia type II","volume":"51","author":"Xiao","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2026100509324694400_cit25","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1007\/s00259-025-07111-7","article-title":"Head-to-head comparison of [18F]FDG, [18F]FMZ, and [18F]SynVesT-1 positron emission tomography imaging in patients with drug-resistant epilepsy","volume":"52","author":"Li","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6c01052","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/5151\/68622940\/mp6c01052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/5151\/68622940\/mp6c01052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:49:37Z","timestamp":1791208177000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/23\/10\/5151\/5436735\/First-In-Human-PET-Imaging-of-Synaptic-Vesicle"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,23]]},"published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c01052","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]}}}